logo.jpg (2815 bytes)
OSTEOPOROSIS BONE DENSITOMETRY
''For better prevention, detection
diagnosis and treatments of Osteoporosis''

1-888-999-4774

Bone Densitometry for
Osteoporosis Detection

-Fee Per Scan
-No Investment Required
-Free Equipment Placement
-Free Ongoing Training

Lunar Corporation Achilles+
Bone Densitometry Equipment


Achilles+ provides fast, comfortable examinations of the os calcis for excellent assessment of osteoporotic fracture risk and the long-term monitoring of treatment.

Indications for Use: The Achilles+ ultrasonometer measures ultrasound variables of the os calcis to provide a clinical measure called the STIFFNESS INDEX. The STIFFNESS INDEX indicates risk of osteoporotic fracture in postmenopausal women comparable to bone mineral density (BMD) as measured by x-ray absorptiometry at the spine or hip. STIFFNESS INDEX results expressed as T-scores are used to assist physicians in the diagnosis of osteoporosis in the same way as are T-scores obtained by x-ray absorptiometry. Either the STIFFNESS INDEX T-score or x-ray absorptiometry T-score can be utilized by a physician, in conjunction with other clinical risk factors, to provide a comprehensive skeletal assessment. The STIFFNESS INDEX has a precision error in older women comparable to that of x-ray absorptiometry which makes it suitable for monitoring bone changes.

 


The Achilles+ ultrasonometer provides a compact, cost-effective solution for evaluating risk of osteoporotic fracture and monitoring bone changes. The rapid, non-invasive measurements are simple to perform and easy to interpret.

Diagnosis
The Achilles+ measures ultrasound properties of the heel. The heel, unlike other peripheral sites, is similar to the proximal femur, since it is load-bearing and rich in trabecular bone. Clinical studies have demonstrated that Achilles+ results predict the risk of femur fracture comparably to dual-energy x-ray absorptiometry of the femur itself.

STIFFNESS INDEX
LUNAR's patented Achilles+ STIFFNESS INDEX results are compared to normal and age-matched reference values, providing a convenient assessment of a patient's skeletal status.

Monitoring
The Achilles+ is the first approved ultrasonometer with a precision error low enough to allow monitoring of bone changes due to disease progression or therapy. Ultrasound is susceptible to variations in both skin coupling and temperature. The Achilles+ utilizes just a few ounces of temperature-controlled water, the optimum coupling medium, to ensure precision of 2% in osteoporotic patients.

Solo or PC Configurations
The Achilles+ offers superior flexibility. In the Solo configuration, the Achilles+ uses an internal computer and self-contained printer, enhancing its transportability. The Achilles+ PC configuration adds database capabilities--useful for patient trending and clinical research--with a laptop or personal computer.

Most Utilized
Achilles+ has been the most utilized ultrasonometer in the world since its 1992 introduction. More than 2,300 Achilles+ units in 45 countries assist doctors in osteoporosis diagnosis.

Healthcare Reimbursement
Achilles+ exams have been reimburseable under Medicare biling code G0133 since July 1, 1998.

[footer.htm]